Healthy Volunteers Clinical Trial
Official title:
A Pilot Study on the Effect of Protein Cross-linking on Gastric Layering and Emptying of a Food Emulsion
| Verified date | June 2012 |
| Source | Institute of Food Research |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: Research Ethics Committee |
| Study type | Interventional |
This comparative pilot study is designed to compare the rates of gastric emptying and by inference rates of digestion of two food emulsions. Two types of milk protein stabilised food emulsion will be compared, one standard emulsion preparation and one emulsion preparation cross-linked with microbial transglutaminase. The information from this study will then be compared to data on satiety and endocrine hormones from a parallel study undertaken in Finland using the same two meal formulations. The drinks will be labeled with a stable isotope of carbon and samples of breath collected every 20 minutes after consumption of the drink. This will allow gastric residence time to be calculated. The pilot will also fulfill two secondary objectives. At the same time as the breath samples are collected MRI scans of the upper abdomen will be made so that gastric volumes can be measured in order to compare the two methods of measuring gastric emptying rates. Additionally, samples of saliva will also be collected after every MRI scan for subsequent mass spectrometry analysis. These are to assess the efficacy of mass spectrometry analysis for detection of the presence of specific digestion related hormones such as ghrelin.
| Status | Completed |
| Enrollment | 4 |
| Est. completion date | June 2012 |
| Est. primary completion date | June 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 20 Years to 50 Years |
| Eligibility |
Inclusion Criteria: - Male (hormonal status of women would introduce more variation within small group) - Age 20-50 years - BMI 19-30 - Apparently healthy - Normally eat lunch - Willing to eat the "milkshake" style emulsion - Provides written informed consent Exclusion Criteria: - You have an allergy or intolerance to rape seed oil, milk or milk proteins including lactose - Smokers or smoked within the last year (smoking affects satiety/hunger) - Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease - Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported - A history of TB or hepatitis. - Regular (more than once in 10 days) use of antacids, laxatives - Diagnosis with any mouth, dental, throat or digestive problem that may affect normal eating and digestion of food. - Take prescription medication for digestive or gastrointestinal conditions. - Volunteers taking part in another study (other than a questionnaire based study). - Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic. - Individuals with special dietary requirements (eg vegetarians) - People with eating disorders (eg. anorexia, bulimia) - If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data. - Refusal to give permission to inform GP of participation in study - Allergic to any of the constituents of the test meal - Recent unexplained weight gain or loss - History of back problems or any other condition which limit ability to repeatedly sit up and lie down - Hiatus Hernia - MRI scanning specific exclusion criteria - Cardiac pacemaker or artificial heart valve - Any surgery in the last 6 months - Aneurysm clips (metal clips from surgery) - Implant, pump or any medical device in the body (eg cochlear implant, neurostimulator, intra-ventricular shunt) - Worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings - Have artificial eyes or limbs - Have been injured with shrapnel or bullets - Suffer from fits, blackouts or epilepsy - Claustrophobia sufferer |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | IFR | Norwich | Norfolk |
| Lead Sponsor | Collaborator |
|---|---|
| Institute of Food Research | Norfolk and Norwich University Hospitals NHS Foundation Trust |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Rate of gastric emptying by MRI | rate measured from MRI images of gastric contents | 20 minute intervals over 3 hours | No |
| Secondary | Gastric emptying by C13 | compare gastric emptying rates measured by MRI with those measured by 13C acetic acid breath tests. | every 20 minutes over 3 hours | No |
| Secondary | mass spectrometry detection of GI tract hormones in saliva | every 20 minutes over 3 hours | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |